A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients

I. Ieiri, S. Yamada, K. Seto, T. Morita, T. Kaneda, K. Mamiya, N. Tashiro, S. Higuchi, K. Otsubo

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The aim of the present study was to seek a CYP2D6 genotypic-phenotypic discordance possibility in Japanese patients under psychotropic drug treatment where the CYP2D6 status and pharmacodynamic responses differ from those in Caucasian psychiatric patients. Ninety drug-free, healthy volunteers and 14 patients undergoing psychotropic drug treatment were phenotyped for their individual CYP2D6 activity using dextromethorphan as a probe, and then the metabolic ratio (MR) was calculated. For the genotyping, eight mutant alleles of the CYP2D6 genes were identified. Serum concentrations of two frequently co-medicated psychotropic drugs, biperiden and levomepromazine, were determined by GC/MS. Genotyping revealed no poor metabolizers (PMs) enrolled in our study. Healthy volunteers exhibited an identical phenotype-genotype concordance, whereas 7 of the 14 patients had significantly high (p < 0.05) MRs compared with genotype-matched volunteers. Three of the patients who had the extensive metabolizer (EM) genotype had extremely high MRs and were classified as phenotypic PMs. Five patients plus all of the seven high MR patients were treated with levomepromazine and/or biperiden, respectively. Their mean serum steady-state concentrations were 27.4 and 7.6 ng/ml, respectively. A CYP2D6 phenotype-genotype mismatch (phenocopying) can occur in Japanese psychiatric patients receiving clinical doses of some psychotropic drugs where the prevalence of PMs is low and the pharmacodynamic responses to those drugs are enhanced compared to Caucasian patients.

Original languageEnglish
Pages (from-to)192-196
Number of pages5
JournalPharmacopsychiatry
Volume36
Issue number5
DOIs
Publication statusPublished - Sep 1 2003

Fingerprint

Cytochrome P-450 CYP2D6
Psychiatry
Genotype
Phenotype
Psychotropic Drugs
Biperiden
Methotrimeprazine
Healthy Volunteers
Dextromethorphan
Serum
Pharmaceutical Preparations
Volunteers
Alleles

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

Ieiri, I., Yamada, S., Seto, K., Morita, T., Kaneda, T., Mamiya, K., ... Otsubo, K. (2003). A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients. Pharmacopsychiatry, 36(5), 192-196. https://doi.org/10.1055/s-2003-43049

A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients. / Ieiri, I.; Yamada, S.; Seto, K.; Morita, T.; Kaneda, T.; Mamiya, K.; Tashiro, N.; Higuchi, S.; Otsubo, K.

In: Pharmacopsychiatry, Vol. 36, No. 5, 01.09.2003, p. 192-196.

Research output: Contribution to journalArticle

Ieiri, I, Yamada, S, Seto, K, Morita, T, Kaneda, T, Mamiya, K, Tashiro, N, Higuchi, S & Otsubo, K 2003, 'A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients', Pharmacopsychiatry, vol. 36, no. 5, pp. 192-196. https://doi.org/10.1055/s-2003-43049
Ieiri, I. ; Yamada, S. ; Seto, K. ; Morita, T. ; Kaneda, T. ; Mamiya, K. ; Tashiro, N. ; Higuchi, S. ; Otsubo, K. / A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients. In: Pharmacopsychiatry. 2003 ; Vol. 36, No. 5. pp. 192-196.
@article{5e2296630293467f9218fdb9f8be0a40,
title = "A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients",
abstract = "The aim of the present study was to seek a CYP2D6 genotypic-phenotypic discordance possibility in Japanese patients under psychotropic drug treatment where the CYP2D6 status and pharmacodynamic responses differ from those in Caucasian psychiatric patients. Ninety drug-free, healthy volunteers and 14 patients undergoing psychotropic drug treatment were phenotyped for their individual CYP2D6 activity using dextromethorphan as a probe, and then the metabolic ratio (MR) was calculated. For the genotyping, eight mutant alleles of the CYP2D6 genes were identified. Serum concentrations of two frequently co-medicated psychotropic drugs, biperiden and levomepromazine, were determined by GC/MS. Genotyping revealed no poor metabolizers (PMs) enrolled in our study. Healthy volunteers exhibited an identical phenotype-genotype concordance, whereas 7 of the 14 patients had significantly high (p < 0.05) MRs compared with genotype-matched volunteers. Three of the patients who had the extensive metabolizer (EM) genotype had extremely high MRs and were classified as phenotypic PMs. Five patients plus all of the seven high MR patients were treated with levomepromazine and/or biperiden, respectively. Their mean serum steady-state concentrations were 27.4 and 7.6 ng/ml, respectively. A CYP2D6 phenotype-genotype mismatch (phenocopying) can occur in Japanese psychiatric patients receiving clinical doses of some psychotropic drugs where the prevalence of PMs is low and the pharmacodynamic responses to those drugs are enhanced compared to Caucasian patients.",
author = "I. Ieiri and S. Yamada and K. Seto and T. Morita and T. Kaneda and K. Mamiya and N. Tashiro and S. Higuchi and K. Otsubo",
year = "2003",
month = "9",
day = "1",
doi = "10.1055/s-2003-43049",
language = "English",
volume = "36",
pages = "192--196",
journal = "Pharmacopsychiatry",
issn = "0176-3679",
publisher = "Georg Thieme Verlag",
number = "5",

}

TY - JOUR

T1 - A CYP2D6 Phenotype-Genotype Mismatch in Japanese Psychiatric Patients

AU - Ieiri, I.

AU - Yamada, S.

AU - Seto, K.

AU - Morita, T.

AU - Kaneda, T.

AU - Mamiya, K.

AU - Tashiro, N.

AU - Higuchi, S.

AU - Otsubo, K.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - The aim of the present study was to seek a CYP2D6 genotypic-phenotypic discordance possibility in Japanese patients under psychotropic drug treatment where the CYP2D6 status and pharmacodynamic responses differ from those in Caucasian psychiatric patients. Ninety drug-free, healthy volunteers and 14 patients undergoing psychotropic drug treatment were phenotyped for their individual CYP2D6 activity using dextromethorphan as a probe, and then the metabolic ratio (MR) was calculated. For the genotyping, eight mutant alleles of the CYP2D6 genes were identified. Serum concentrations of two frequently co-medicated psychotropic drugs, biperiden and levomepromazine, were determined by GC/MS. Genotyping revealed no poor metabolizers (PMs) enrolled in our study. Healthy volunteers exhibited an identical phenotype-genotype concordance, whereas 7 of the 14 patients had significantly high (p < 0.05) MRs compared with genotype-matched volunteers. Three of the patients who had the extensive metabolizer (EM) genotype had extremely high MRs and were classified as phenotypic PMs. Five patients plus all of the seven high MR patients were treated with levomepromazine and/or biperiden, respectively. Their mean serum steady-state concentrations were 27.4 and 7.6 ng/ml, respectively. A CYP2D6 phenotype-genotype mismatch (phenocopying) can occur in Japanese psychiatric patients receiving clinical doses of some psychotropic drugs where the prevalence of PMs is low and the pharmacodynamic responses to those drugs are enhanced compared to Caucasian patients.

AB - The aim of the present study was to seek a CYP2D6 genotypic-phenotypic discordance possibility in Japanese patients under psychotropic drug treatment where the CYP2D6 status and pharmacodynamic responses differ from those in Caucasian psychiatric patients. Ninety drug-free, healthy volunteers and 14 patients undergoing psychotropic drug treatment were phenotyped for their individual CYP2D6 activity using dextromethorphan as a probe, and then the metabolic ratio (MR) was calculated. For the genotyping, eight mutant alleles of the CYP2D6 genes were identified. Serum concentrations of two frequently co-medicated psychotropic drugs, biperiden and levomepromazine, were determined by GC/MS. Genotyping revealed no poor metabolizers (PMs) enrolled in our study. Healthy volunteers exhibited an identical phenotype-genotype concordance, whereas 7 of the 14 patients had significantly high (p < 0.05) MRs compared with genotype-matched volunteers. Three of the patients who had the extensive metabolizer (EM) genotype had extremely high MRs and were classified as phenotypic PMs. Five patients plus all of the seven high MR patients were treated with levomepromazine and/or biperiden, respectively. Their mean serum steady-state concentrations were 27.4 and 7.6 ng/ml, respectively. A CYP2D6 phenotype-genotype mismatch (phenocopying) can occur in Japanese psychiatric patients receiving clinical doses of some psychotropic drugs where the prevalence of PMs is low and the pharmacodynamic responses to those drugs are enhanced compared to Caucasian patients.

UR - http://www.scopus.com/inward/record.url?scp=0242383525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242383525&partnerID=8YFLogxK

U2 - 10.1055/s-2003-43049

DO - 10.1055/s-2003-43049

M3 - Article

C2 - 14571354

AN - SCOPUS:0242383525

VL - 36

SP - 192

EP - 196

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

SN - 0176-3679

IS - 5

ER -